In clinical studies, formal response criteria have been developed and have gained wide acceptance. The National Cancer Institute (NCI) has proposed and implemented newer standard response criteria called Response Evaluation Criteria in Solid Tumors (RECIST). In contrast, the World Health Organization (WHO) has a different standard for assessing response. Major differences between these guidelines are outlined below.
Despite the fact that it is highly curable if diagnosed early, ovarian cancer causes more mortality in American women each year than all other gynecologic malignancies combined.
This management guide covers the symptoms, diagnosis, screening, staging, and treatment of multiple myeloma, smoldering myeloma, and other plasma cell dyscrasias.
This list of chemotherapeutic agents covers the cancers each drug is used for, as well as the recommended dosage and possible toxicities of the therapy.
Myelodysplastic syndromes (MDS) are a group of hematologic malignancies of the pluripotent hematopoietic stem cells. These disorders are characterized by ineffective hematopoiesis, including abnormalities in proliferation, differentiation, and apoptosis.
This management guide covers the risk factors, screening, diagnosis, staging, and treatment of acute leukemias.
This management guide for non–small-cell lung cancer (NSCLC) covers the symptoms, screening, diagnosis, staging, and treatment of adenocarcinoma, squamous cell carcinoma, and large-cell carcinoma of the lung.
Myeloproliferative neoplasms are a group of clonal myeloid cell–derived disorders characterized by myeloproliferation without dysplasia, bone marrow hypercellularity, and predisposition to thrombosis, hemorrhage, and bone marrow fibrosis.
Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder resulting from the neoplastic transformation of the primitive hematopoietic stem cell.
Young adult female cancer survivors have unmet informational needs regarding reproductive issues and decisional conflict regarding fertility preservation.
A new study has suggested two new ways to report on adverse events in the era of molecularly targeted therapies.
The use of ADT along with modern dose-escalated RT does not improve survival vs RT alone in men with favorable intermediate-risk prostate cancer.
The UK Lung Cancer Screening Trial found that a low-dose CT screening program targeting high-risk individuals can find lung cancer at early stages.
ASCO has released a clinical practice guideline on invasive cervical cancer. For the first time, ASCO created the guideline based on resource availability, tailoring recommendations to support basic- or limited-resource settings.
In this Medical News Minute, developed exclusively for Cancer Network, Dr. Bobby Lazzara discusses a joint effort from the American Cancer Society and IBM that aims to use the cognitive power of Watson to help cancer patients deal with their disease.
A new study has identified several trends by race and ethnicity among patients with hepatocellular carcinoma (HCC) in the United States.
The accuracy of interpreting a breast cancer screening mammogram is not diminished as clinicians get toward the end of a session.
Gonadotropin-releasing hormone agonist (GnRHa) did not prevent chemotherapy-induced premature ovarian failure in young women with lymphoma.
Half of all cancer deaths and 20% to 40% of cancer cases in the United States could potentially be prevented if individuals adopted healthier lifestyles, according to a new study.
Do you know incidence of lung cancer in the United States? How about which lymph node station is not evaluable with esophageal ultrasound-guided biopsy in newly diagnosed disease? Answer these questions and more.
Partaking in physical activity was associated with a reduction in risk for as many as 13 cancer types regardless of body size or smoking history.
Although data are anecdotal, there is no question that the increased numbers of patients with insurance resulted in cancer patients receiving care they previously could not.
In this Medical News Minute, developed exclusively for Cancer Network, Dr. Bobby Lazzara examines a recent report that warns of different factors associated with an increased risk of stomach cancer.
A new study showed that as cancer survivors age, they have greater declines in certain physical health conditions, as well as an increased risk for depression.
Regular use of aspirin may reduce the risk of developing cholangiocarcinoma, according to the results of a new study.
Dr. Alan Blum and Cancer Network have partnered to assemble a four-part slideshow series addressing the history of America’s smoking pandemic. Part 3 highlights a period of regulation and legislation against the tobacco industry, and litigation in the form of class action and state lawsuits.
No matter where you practice medicine, if your duties include patient care then you are going to interact with other oncologists. In some cases you may question the quality of their care. Help your peers to become better physicians by respecting them first, then relaying your concerns to them. Here are some examples of how not to do it, paired with kinder, gentler alternatives.
While oncologic emergencies are common among cancer patients, they can often be avoided with close monitoring, early intervention, and ongoing patient education.
Cognitive behavioral therapy may reduce long-term memory-related issues linked to chemotherapy treatment in cancer survivors.
Do you know the prevalence of triple-negative breast cancer? How about the patient makeup in the START A and START B trials, which tested hypofractionated radiotherapy for breast cancer? Answer these questions and more.